Partner Headlines - THRX

  1. UPDATE: Morgan Stanley Reiterates On Theravance As Slow Trends ...

    Benzinga
  2. Theravance, Inc. Appoints Theodore J. Witek, Jr. As Senior VP, ...

    Benzinga
  3. UPDATE: Stifel Downgrades Theravance Following Post-Split Accretion

    Benzinga
  4. Benzinga's Top Downgrades

    Benzinga
  5. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies ...

    Benzinga
  6. Theravance Announces Positive Results From a Phase 2 Study of ...

    Benzinga
  7. Theravance Announces Initiation of Phase 2b Study With TD-42 ...

    Benzinga
  8. Glaxo's COPD Drug Gets European Green Light

    FoxBusiness
  9. Morgan Stanley Expects Theravance to Continue to Underperform ...

    Benzinga
  10. Top 2013 Drug Approvals: Pharma Stocks

    YCharts
  11. Positive data for asthma drug

    IBD
  12. Theravance, Glaxo COPD Drug Does Well In Asthma

    IBD
  13. Seth Klarman Buys Micron Technology, Theravance, PBF Energy, ...

    GuruFocus
  14. GlaxoSmithKline

    IBD
  15. US Stock Futures Signal Flat Start On Wall Street

    Benzinga
  16. Relvar Ellipta Approved in Japan for Treatment of Asthma

    Benzinga
  17. Glaxo, Theravance Confirm Positive CHMP Opinion for Relvar Ellipta

    Benzinga
  18. Glaxo, Theravance Confirms FDA Panel Has Recommended Approval ...

    Benzinga
  19. Theravance Reports Results from Phase 2B Study 0091 with TD-42 ...

    Benzinga
  20. Missed Klarman’s 47% Gainer? His Other Value Pick

    YCharts
  21. Seth Klarman's Top 5 Second Quarter Holdings

    GuruFocus
  22. Perrigo-Elan Merger Creates Unlikely Pharma Union

    IBD
  23. UPDATE: Stifel Nicolaus Cuts PT to $37 on Theravance Ahead of ...

    Benzinga
  24. Theravance to Offer $250 Million Convertible Subordinated Notes ...

    Benzinga
  25. Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN

    GuruFocus
  26. Theravance Confirms Favorable Ruling from FDA Panel on VIBATIV

    Benzinga
  27. Theravance Offers FDA Briefing Documents for Panel Meeting on ...

    Benzinga
  28. Theravance Enters Agreement With Alfa Wassermann Worth Up To ...

    Benzinga
  29. The Baupost Group's Favorite Stocks

    Benzinga
  30. Theravance Inc. (THRX) Sr VP, CFO Michael W Aguiar sells 24,682 ...

    GuruFocus
  31. GSK and Theravance Announce Completion of the Phase III Programme ...

    Benzinga
  32. Weekly CFO Sells Highlight: SWN, BECN, NSIT, HOLX, QLTI, THRX

    GuruFocus
  33. Theravance Inc. (THRX) Sr VP, CFO Michael W Aguiar sells 60, ...

    GuruFocus
  34. Theravance Inc. (THRX) CEO Rick E Winningham sells 75,749 Shares

    GuruFocus
  35. A Peek Into The Market Before The Trading Starts

    Benzinga
  36. GSK and Theravance Announce Regulatory Submissions for FF/VI ...

    Benzinga
  37. Target, Amgen Among Stocks Hitting 52-Week Highs Wednesday

    FoxBusiness
  38. Dendreon, Pharmacyclics and Other Biotech Takeover Targets

    Benzinga
  39. Merck &, Questcor Pharmaceuticals, Other Stocks Hit 52-Week Highs ...

    FoxBusiness
  40. Health Care Sector Wrap

    FoxBusiness
  41. Health Care Sector Wrap

    FoxBusiness
  42. GSK and Theravance Announce Positive Results From Four Pivotal ...

    Benzinga
  43. Theravance Inc. Reports Operating Results (10-K)

    GuruFocus
  44. UPDATE: Morgan Stanley Initiates Underweight, $12 PT on Theravance

    Benzinga
  45. Morgan Stanley Initiates Theravance at Underweight

    Benzinga
  46. Afternoon Movers; Markets Moved Higher

    Benzinga
  47. Morning Market Losers

    Benzinga
  48. From Earlier: GSK and Theravance Announce Initial Outcomes From ...

    Benzinga
  49. UPDATE: Piper Jaffray Raises Price Target on Theravance to $35

    Benzinga
  50. Piper Jaffray Raises PT on Theravance to $35

    Benzinga
  51. Notable Put Options Activity in Theravance

    Benzinga
  52. Theravance Inc. (THRX) Sr VP, CFO Michael W Aguiar sells 10, ...

    GuruFocus
Trading Center